Compugen Beats Q3 Loss Expectations
Update: 2025-11-10
Description
Compugen Limited, an Israel-based drug developer, reported a net loss of seven million dollars for Q3, surpassing Wall Streets expectations of a nine cents per share loss. Despite the loss, the companys revenue of one point nine million dollars and ability to beat analysts predictions is noteworthy for investors.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
